[contact-form-7 id="15592" title="Tell me more"]

Contact Next Edge Capital

1 Toronto Street, Suite 200
Toronto, ON M5C 2V6

Telephone: 416.775.3600
Toll-free: 1.877.860.1080
Fax: 416.775.3601
Email: info@nextedgecapital.com

Next Edge Bio-Tech Fund

Next Edge Bio-Tech fund

KaloBios: The frenzied second act for ‘the most hated CEO in America’

Nov 10th, 2015

<< Return to News

KaloBios: The frenzied second act for ‘the most hated CEO in America’

November 25th 2015

The current prime villain of Wall Street has shaken up the biotech space once again. Turing Pharmaceuticals AGCEO Martin Shkreli gained notorietyin September for raising the price of a parasitic-infection drug to $750 (U.S.) a tablet from $13.50.

View the article

Fund Type
Commodity Pool
Inception Date
2009-12-29
Minimum Initial Investment
CAD $5,000
Purchases / Redemptions
Weekly before 4pm (EST) on the third business day immediately preceding a redemption date.
Management Fee
Class A
2.25% per annum (1.25% servicing fee, payable out of the MGMT fee);
Class F
1.00% per annum
Valuation Pricing
Weekly
Fund Codes
Class A - NEC 111
Class F - NEC 173